Stock Earnings

Question 1

What are Rigel Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Rigel Pharmaceuticals Inc has a total asset of $163, Net profit of $17

Question 2

What are the key financial ratios for RIGL?

Accepted Answer

Rigel Pharmaceuticals Inc's Current ratio is 1.01, has a Net margin is 9.49, sales per share of $10.12.

Question 3

How is Rigel Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Rigel Pharmaceuticals Inc largest revenue segment is Novel Therapies, at a revenue of 116,882,000 in the most earnings release.For geography, United States is the primary market for Rigel Pharmaceuticals Inc, at a revenue of 116,882,000.

Question 4

Is Rigel Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Rigel Pharmaceuticals Inc has a net profit of $17

Question 5

Does Rigel Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Rigel Pharmaceuticals Inc has liability of 160

Question 6

How many outstanding shares for Rigel Pharmaceuticals Inc?

Accepted Answer

Rigel Pharmaceuticals Inc has a total outstanding shares of 17.71

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	267	179	116	120	149	108
Revenue Growth (YoY)	105%	54%	-3%	-19%	38%	83%
Cost of Revenue	22	18	7	1	1	0
Gross Profit	245	160	109	118	148	107
Selling, General & Admin	113	113	105	112	91	76
Research & Development	27	23	24	60	65	60
Operating Expenses	140	136	130	172	157	136
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	99	18	-25	-58	-17	-29
Income Tax Expense	1	0	--	0	0	--
Net Income	97	17	-25	-58	-17	-29
Net Income Growth	-793%	-168%	-56.99%	241%	-41%	-56%
Shares Outstanding (Diluted)	18.16	17.68	17.4	172.4	170.5	168.8
Shares Change (YoY)	3%	2%	-90%	1%	1%	1%
EPS (Diluted)	5.38	0.98	-1.44	-0.34	-0.11	-0.18
EPS Growth	-764%	-169%	324%	209%	-39%	-55%
Free Cash Flow	65	31	-20	-74	5	-53
Free Cash Flow Per Share	3.57	1.75	-1.14	-0.42	0.02	-0.31
Gross Margin	91.76%	89.38%	93.96%	98.33%	99.32%	99.07%
Operating Margin	38.95%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Profit Margin	36.32%	9.49%	-21.55%	-48.33%	-11.4%	-26.85%
Free Cash Flow Margin	24.34%	17.31%	-17.24%	-61.66%	3.35%	-49.07%
EBITDA	106	26	-19	-53	-8	-29
EBITDA Margin	39.7%	14.52%	-16.37%	-44.16%	-5.36%	-26.85%
D&A For EBITDA	2	2	1	1	1	0
EBIT	104	24	-20	-54	-9	-29
EBIT Margin	38.95%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Effective Tax Rate	1.01%	0%	--	0%	0%	--

Rigel Pharmaceuticals Inc (RIGL) Price

RIGL Stock Price Chart

RIGL Income

Follow-Up Questions